RFL

Rafael Holdings owns stakes in pharmaceutical and medical device companies in the United States and Israel. The company is developing drugs to treat rare genetic disorders and certain cancers, with several candidates currently in clinical trials testing their safety and effectiveness in people. It is also working on surgical devices, including instruments for treating Carpal Tunnel syndrome. The company was founded in 2017 and is based in Newark, New Jersey.